BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22492239)

  • 1. Introduction to this special issue on tumor targeting.
    Goldenberg DM
    Tumour Biol; 2012 Jun; 33(3):571-2. PubMed ID: 22492239
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
    Britton KE
    Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacology.
    Prabhu S; Boswell CA; Leipold D; Khawli LA; Li D; Lu D; Theil FP; Joshi A; Lum BL
    Ther Deliv; 2011 Jun; 2(6):769-91. PubMed ID: 22822508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct route may not be the best way to home.
    Sharkey RM
    J Nucl Med; 2005 Mar; 46(3):391-4. PubMed ID: 15750148
    [No Abstract]   [Full Text] [Related]  

  • 5. Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy.
    Srivastava SC
    Cancer Biother Radiopharm; 1996 Feb; 11(1):43-50. PubMed ID: 10851519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoconjugates. Targeting disease for diagnosis and treatment.
    Tilyou SM
    J Nucl Med; 1990 Dec; 31(12):15A-20A, 30A. PubMed ID: 2266383
    [No Abstract]   [Full Text] [Related]  

  • 7. The 10th International Conference on Monoclonal Antibody Immunoconjugates for Cancer: Radiodosimetry and Radiopharmaceuticals for Therapy.
    Breitz H; Mills G; Siegel J; Stabin M; Wessels BW
    Cancer Biother Radiopharm; 1996 Feb; 11(1):25-42. PubMed ID: 10851518
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
    Kawashima H
    ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
    Zalutsky MR; Schuster JM; Garg PK; Archer GE; Dewhirst MW; Bigner DD
    Recent Results Cancer Res; 1996; 141():101-22. PubMed ID: 8722422
    [No Abstract]   [Full Text] [Related]  

  • 10. Second Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Princeton, New Jersey, September 8-10, 1988. Proceedings.
    Cancer Res; 1990 Feb; 50(3 Suppl):774s-1059s. PubMed ID: 2297722
    [No Abstract]   [Full Text] [Related]  

  • 11. Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate.
    Schubiger PA; Alberto R; Smith A
    Bioconjug Chem; 1996; 7(2):165-79. PubMed ID: 8983338
    [No Abstract]   [Full Text] [Related]  

  • 12. [New radiopharmaceuticals for oncologic diagnosis and therapy: developments in radioimmunoscintigraphy and radioimmunotherapy].
    Eisenhut M; Brandau W; Reinel U; Kimmig B
    Rontgenblatter; 1989 Jan; 42(1):24-7. PubMed ID: 2645635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in immunoconjugate cancer therapeutics.
    Payne G
    Cancer Cell; 2003 Mar; 3(3):207-12. PubMed ID: 12676579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors--a review of radiolabeling characteristics, quality control and in vitro stability studies.
    Iznaga-Escobar N
    Appl Radiat Isot; 2001 Mar; 54(3):399-406. PubMed ID: 11214873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of monoclonal antibody immunoconjugates in cancer therapy.
    Pietersz GA; Krauer K; McKenzie IF
    Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models for radiolabeled monoclonal antibodies in cancer research.
    Aas M; Fjeld JG
    Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeting: taking an alternate route for localizing radionuclides.
    Sharkey RM; Chang CH; Rossi EA; McBride WJ; Goldenberg DM
    Tumour Biol; 2012 Jun; 33(3):591-600. PubMed ID: 22396041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.